Palmidrol CAS 544-31-0: Comprehensive User Guide
Table of Contents
1. Product Overview & Comparative Analysis
Palmitoylethanolamide (PEA) derivative, Palmidrol CAS 544-31-0, is a synthetic fatty acid amide with proven anti-inflammatory and neuroprotective properties. Key specifications include:
| Parameter | Palmidrol CAS 544-31-0 | Standard PEA | Competitor X |
|---|---|---|---|
| Molecular Formula | C19H39NO2 | C16H25NO2 | C18H37NO3 |
| Purity | ≥99% | ≥95% | ≥97% |
| Applications | Pharma, Cosmetics, Nutraceuticals | Limited to Pharma | Cosmetics Only |
2. Applications of Palmidrol CAS 544-31-0
2.1 Pharmaceutical Uses
Used in chronic pain management formulations due to its ability to modulate CB1/CB2 receptors without psychoactive effects.
2.2 Cosmetic Applications
Reduces skin inflammation in anti-aging creams and eczema treatments (e.g., 0.5-2% concentration in serums).
2.3 Nutraceutical Integration
Key component in dietary supplements targeting neuropathic pain, with recommended daily intake of 300-600mg.
3. Usage Scenarios & Best Practices
3.1 Topical Formulation Protocol
Combine with 5% DMSO for enhanced transdermal absorption in anti-inflammatory creams.
3.2 Oral Supplement Production
Microencapsulate with liposomes for improved bioavailability in capsule formulations.
4. Customer Success Stories
4.1 PharmaCorp Ltd. (Germany)
Integrated Palmidrol into their neuropathic pain drug, achieving 40% faster pain reduction vs placebo in Phase III trials.
4.2 DermaSolutions Inc. (USA)
Developed a psoriasis cream with 1.8% Palmidrol concentration, reducing inflammation markers by 62% within 4 weeks.
4.3 NutraHealth Group (UK)
Launched a best-selling supplement combining Palmidrol with curcumin, yielding 300% ROI in first year.
5. Contact for Custom Solutions
Request formulation guidance or bulk pricing:
⚠️ Note: All transactions comply with REACH and FDA regulatory standards.



评论
目前还没有评论。